- Home
- MDAIW vs ACGLO Comparison
MDAIW vs ACGLO Comparison
Compare MDAIW & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAIW
- ACGLO
- Stock Information
- Founded
- MDAIW N/A
- ACGLO N/A
- Country
- MDAIW United States
- ACGLO Bermuda
- Employees
- MDAIW 78
- ACGLO 5800
- Industry
- MDAIW Medical/Dental Instruments
- ACGLO Property-Casualty Insurers
- Sector
- MDAIW Health Care
- ACGLO Finance
- Exchange
- MDAIW Nasdaq
- ACGLO Nasdaq
- Market Cap
- MDAIW N/A
- ACGLO N/A
- IPO Year
- MDAIW N/A
- ACGLO N/A
- Fundamental
- Price
- MDAIW $0.49
- ACGLO $21.82
- Analyst Decision
- MDAIW
- ACGLO
- Analyst Count
- MDAIW 0
- ACGLO 0
- Target Price
- MDAIW N/A
- ACGLO N/A
- AVG Volume (30 Days)
- MDAIW 35.6K
- ACGLO N/A
- Earning Date
- MDAIW 02-27-2025
- ACGLO N/A
- Dividend Yield
- MDAIW N/A
- ACGLO N/A
- EPS Growth
- MDAIW N/A
- ACGLO N/A
- EPS
- MDAIW N/A
- ACGLO N/A
- Revenue
- MDAIW $27,264,000.00
- ACGLO N/A
- Revenue This Year
- MDAIW N/A
- ACGLO N/A
- Revenue Next Year
- MDAIW N/A
- ACGLO N/A
- P/E Ratio
- MDAIW N/A
- ACGLO N/A
- Revenue Growth
- MDAIW 44.52
- ACGLO N/A
- 52 Week Low
- MDAIW $0.08
- ACGLO N/A
- 52 Week High
- MDAIW $0.90
- ACGLO N/A
- Technical
- Relative Strength Index (RSI)
- MDAIW N/A
- ACGLO 69.24
- Support Level
- MDAIW N/A
- ACGLO $21.21
- Resistance Level
- MDAIW N/A
- ACGLO $21.70
- Average True Range (ATR)
- MDAIW 0.00
- ACGLO 0.19
- MACD
- MDAIW 0.00
- ACGLO 0.02
- Stochastic Oscillator
- MDAIW 0.00
- ACGLO 91.14
About MDAIW Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.